Search Results 2131-2140 of 21359 for anti-TNF drugs

  1. Entecavir (Oral Route) Proper Use - Mayo Clinic

    Read and follow carefully the patient information leaflet before starting entecavir treatment and each time you refill. Ask your doctor or pharmacist if you ...

  2. A Study to Evaluate TG4050 in Ovarian Carcinoma - Mayo Clinic

    By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA-4. Patients with ... Patients under chronic treatment with systemic corticosteroids or other ...

  3. Publications - Lionel A. Kankeu Fonkoua, M.D. - Mayo Clinic

    Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

  4. Fondaparinux (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    By condition, treatment or drug ... anti-HBs) are eligible to participate in the study. ... Treatment with another investigational drug (including investigational ...

  6. Oxycodone And Ibuprofen (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Rosiglitazone And Metformin (Oral Route) Precautions - Mayo Clinic

    Also, carry an ID card in your wallet or purse that says that you have diabetes and a list of all of your medicines. Symptoms of fluid retention—Know what to do ...

  8. Nursing - Overview - Mayo Clinic

    We were throwing every therapy at him, but he didn't improve. Therapy after therapy, intervention after intervention. Becky Herber: They had done everything ...

  9. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    ... therapy; Prior treatment with an anti-PD-1, anti-PD-L1, or anti-PD-L2; Prior treatment with a known poly(ADP-ribose) polymerase (PARP) inhibitor; Heart-rate ...

  10. Infectious Diseases - Overview - Mayo Clinic

    This therapy significantly reduced the hospitalization rate and decreased mortality of people showing symptoms of infection with the virus that causes COVID-19 ...